News & events
-
National Drug Codes
Read MoreAccording to the Food and Drug Administration (FDA), drugs are identified and reported using a unique, three-segment number called the National Drug Code (NDC) which serves as the FDA’s identifier for drugs. FDA publishes the listed NDC numbers in the NDC Directory which is updated daily.
-
Particulate Matter Testing
Read MoreWhat is particulate matter and why is testing performed?
Particulate matter is unwanted solid material in solutions for injection. Particle counts that exceed USP limits in intravenous drug products could block blood flow inside the patient’s body causing paralysis or death.
-
OOS Investigation Part 2
Read MoreARL’s out-of-specification investigations use a hybrid approach to review data, formulations, and tests. Our data reviewers consult with ARL’s scientific directors and clients to ensure we provide a 360-view investigation and evaluate all aspects of the laboratory, data, and client and analyst trends. Typical investigations are concluded within one week or within 4 business days after the due date.
-
OOS Investigation Part 1
Read MoreUnited States Pharmacopeia monographs establish standards for identity, strength, quality, and purity of medicines. Monographs list tests and acceptance criteria (usually expressed in percentage ranges or limits). Drug substances and products should meet the acceptance criteria to be considered acceptable for its intended use.
-
Minor Chapters Major Impacts
Read MoreMinor Chapters, Major Impacts – What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> mean for your compounding practiceBrian Kelley, BS, ARL Bio Pharma Director of Business DevelopmentInternational Journal of Pharmaceutical Compounding, Vol. 25, No. 2, March / April 2021, p. 115-124 Abstract The United States Pharmacopeial Convention, Inc. recommends within the standards of
-
Tests for Burkholderia cepacia Complex
Read MoreJames Zellner, ARL Bio Pharma Technical Sales and Microbiologist USP <60>, Microbiological Examination of Nonsterile Products – Tests for Burkholderia cepacia Complex, describes a test procedure that evaluates the microbiological quality, specifically the presence of species of the genus Burkholderia, in non-sterile substances and preparations. This is important, because Burkholderia is a potentially dangerous pathogen, especially for drugs or raw materials that